MX367633B - Nueva sintesis quiral de n-acil-(3-sustituidas)-(8-sustituidas)-5, 6-dihidro-[1,2,4]triazolo[4,3-a]pirazinas. - Google Patents

Nueva sintesis quiral de n-acil-(3-sustituidas)-(8-sustituidas)-5, 6-dihidro-[1,2,4]triazolo[4,3-a]pirazinas.

Info

Publication number
MX367633B
MX367633B MX2017003980A MX2017003980A MX367633B MX 367633 B MX367633 B MX 367633B MX 2017003980 A MX2017003980 A MX 2017003980A MX 2017003980 A MX2017003980 A MX 2017003980A MX 367633 B MX367633 B MX 367633B
Authority
MX
Mexico
Prior art keywords
substituted
pyrazines
dihydro
acyl
triazolo
Prior art date
Application number
MX2017003980A
Other languages
English (en)
Other versions
MX2017003980A (es
Inventor
Dutheuil Guillaume
Hoveyda Hamid
Original Assignee
Ogeda S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ogeda S A filed Critical Ogeda S A
Publication of MX2017003980A publication Critical patent/MX2017003980A/es
Publication of MX367633B publication Critical patent/MX367633B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

La presente invención se refiere a una nueva sintesis quiral de N-acil-(3-sustituidas)-(8-sustituidas)-5,6-dihidro- [1,2,4]triazolo[4,3-a]pirazinas de la Formula I, evitando el uso de etapas de proteccion/desproteccion. (ver formula).
MX2017003980A 2014-09-25 2015-09-25 Nueva sintesis quiral de n-acil-(3-sustituidas)-(8-sustituidas)-5, 6-dihidro-[1,2,4]triazolo[4,3-a]pirazinas. MX367633B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14186447 2014-09-25
PCT/EP2015/072167 WO2016046398A1 (en) 2014-09-25 2015-09-25 Novel chiral synthesis of n-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines

Publications (2)

Publication Number Publication Date
MX2017003980A MX2017003980A (es) 2017-05-08
MX367633B true MX367633B (es) 2019-08-29

Family

ID=51730305

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017003980A MX367633B (es) 2014-09-25 2015-09-25 Nueva sintesis quiral de n-acil-(3-sustituidas)-(8-sustituidas)-5, 6-dihidro-[1,2,4]triazolo[4,3-a]pirazinas.

Country Status (18)

Country Link
US (2) US20170298070A1 (es)
EP (1) EP3197876B1 (es)
JP (1) JP6469214B2 (es)
KR (1) KR102558711B1 (es)
CN (1) CN107001289B (es)
AU (1) AU2015323702B2 (es)
CA (1) CA2961984C (es)
EA (1) EA032052B1 (es)
ES (1) ES2711095T3 (es)
IL (1) IL251304B (es)
MX (1) MX367633B (es)
NZ (1) NZ730295A (es)
PL (1) PL3197876T3 (es)
PT (1) PT3197876T (es)
SG (2) SG10201800162RA (es)
TR (1) TR201902080T4 (es)
WO (1) WO2016046398A1 (es)
ZA (1) ZA201701949B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2763992B9 (en) 2011-10-03 2016-08-24 Euroscreen S.A. Novel chiral n-acyl-5,6,7,(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective nk-3 receptor antagonists, pharmaceutical composition, and methods for use in nk-3 receptor mediated disorders
US10183948B2 (en) 2013-03-29 2019-01-22 Ogeda Sa N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists
ES2646488T3 (es) 2013-03-29 2017-12-14 Ogeda S.A. N-acil-(3-sustituido)-(8-sustituido)-5,6-dihidro-[1,2,4]triazolo[4,3-a]pirazinas como antagonistas selectivos del receptor NK-3, composición farmacéutica, métodos para uso en trastornos mediados por el receptor NK-3
EP3271015B8 (en) 2015-03-16 2023-11-01 Ogeda N.V. Nk-3 receptor antagonists for therapeutic or cosmetic treatment of excess body fat
JP2021014404A (ja) * 2017-10-13 2021-02-12 アステラス製薬株式会社 トリアゾロピラジン誘導体の塩及び結晶
US20230271967A1 (en) 2020-08-04 2023-08-31 Teva Pharmaceuticals International Gmbh Solid state forms of fezolinetant and salts thereof

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3252483B2 (ja) 1992-10-20 2002-02-04 東レ株式会社 ３環性トリアゾロ誘導体の製造方法
MXPA01009871A (es) 1999-04-01 2002-04-24 Pfizer Prod Inc Aminopiridinas como inhibidores de la sorbitol deshidrogenasa.
DE60316416T2 (de) 2002-03-25 2008-06-26 Merck & Co., Inc. Heterocyclische beta-aminoverbindungen als inhibitoren der dipeptidylpeptidase zur behandlung bzw. prävention von diabetes
ATE335744T1 (de) 2002-08-07 2006-09-15 Novartis Pharma Gmbh Organische verbindungen als mittel zur behandlung von aldosteronbedingten zuständen
MY139563A (en) 2002-09-04 2009-10-30 Bristol Myers Squibb Co Heterocyclic aromatic compounds useful as growth hormone secretagogues
AR043443A1 (es) 2003-03-07 2005-07-27 Merck & Co Inc Procedimiento de preparacion de tetrahidrotriazolopirazinas y productos intermedios
PL1716152T3 (pl) 2004-02-18 2009-01-30 Astrazeneca Ab Skondensowane związki heterocykliczne i ich zastosowanie jako antagonistów receptora metabotropowego do leczenia zaburzeń żołądkowo-jelitowych
TWI378091B (en) 2006-03-09 2012-12-01 Eisai R&D Man Co Ltd Multi-cyclic cinnamide derivatives
US8329709B2 (en) 2008-01-09 2012-12-11 Genentech, Inc. 5H-cyclopenta[D]pyrimidines as AKT protein kinase inhibitors
EP2229394A1 (en) 2008-01-17 2010-09-22 Grünenthal GmbH Substituted sulfonamide derivatives
ES2590987T3 (es) * 2009-04-29 2016-11-24 Glaxo Group Limited Derivados de 5,6,7,8-tetrahidro[1,2,4]triazolo[4,3-a]pirazina como moduladores de P2X7
JPWO2011007756A1 (ja) 2009-07-13 2012-12-27 武田薬品工業株式会社 複素環化合物及びその用途
DK2552920T3 (en) 2010-04-02 2017-06-12 Ogeda Sa UNKNOWN UNKNOWN NK-3 RECEPTOR SELECTIVE ANTAGONIST RELATIONS, PHARMACEUTICAL COMPOSITION AND METHODS FOR USE IN NK-3 RECEPTOR-MEDIUM DISORDERS
US10065960B2 (en) 2010-04-02 2018-09-04 Ogeda Sa NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disorders
EP2763992B9 (en) * 2011-10-03 2016-08-24 Euroscreen S.A. Novel chiral n-acyl-5,6,7,(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective nk-3 receptor antagonists, pharmaceutical composition, and methods for use in nk-3 receptor mediated disorders
AU2014242907B2 (en) 2013-03-29 2018-06-28 Ogeda Sa Novel N-acyl-(3-substituted)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor-mediated disorders
ES2721018T3 (es) 2013-03-29 2019-07-26 Ogeda S A N-Acil-(3-sustituido)-(8-metil)-5,6-dihidro-[1,2,4]triazolo[4,3-a]pirazinas como antagonistas selectivos del receptor NK-3, composición farmacéutica, métodos para su uso en trastornos mediados por el receptor de NK-3
ES2646488T3 (es) 2013-03-29 2017-12-14 Ogeda S.A. N-acil-(3-sustituido)-(8-sustituido)-5,6-dihidro-[1,2,4]triazolo[4,3-a]pirazinas como antagonistas selectivos del receptor NK-3, composición farmacéutica, métodos para uso en trastornos mediados por el receptor NK-3

Also Published As

Publication number Publication date
ZA201701949B (en) 2021-06-30
NZ730295A (en) 2023-05-26
EA201790540A1 (ru) 2017-07-31
KR20170072898A (ko) 2017-06-27
PT3197876T (pt) 2019-02-21
JP6469214B2 (ja) 2019-02-13
EP3197876B1 (en) 2018-11-28
US20190218225A1 (en) 2019-07-18
SG11201702368PA (en) 2017-04-27
US20170298070A1 (en) 2017-10-19
SG10201800162RA (en) 2018-02-27
PL3197876T3 (pl) 2019-05-31
BR112017005880A2 (pt) 2018-02-06
AU2015323702B2 (en) 2020-03-12
CN107001289B (zh) 2019-12-31
IL251304B (en) 2019-07-31
JP2017529370A (ja) 2017-10-05
US10787458B2 (en) 2020-09-29
EA032052B1 (ru) 2019-03-29
KR102558711B1 (ko) 2023-07-21
ES2711095T3 (es) 2019-04-30
EP3197876A1 (en) 2017-08-02
TR201902080T4 (tr) 2019-03-21
CA2961984A1 (en) 2016-03-31
CN107001289A (zh) 2017-08-01
CA2961984C (en) 2023-01-24
AU2015323702A1 (en) 2017-04-13
IL251304A0 (en) 2017-05-29
MX2017003980A (es) 2017-05-08
WO2016046398A1 (en) 2016-03-31

Similar Documents

Publication Publication Date Title
MX2017003980A (es) Nueva sintesis quiral de n-acil-(3-sustituidas)-(8-sustituidas)-5, 6-dihidro-[1,2,4]triazolo[4,3-a]pirazinas.
HK1245764A1 (zh) 3-取代的5-氨基-6h-噻唑並[4，5-d]嘧啶-2，7-二酮化合物
PH12016502177A1 (en) Processes of preparing a jak1 inhibitor and new forms thereto
AU2014270524A8 (en) 2-phenylimidazo [1,2-a]pyrimidines as imaging agents
PH12015501934B1 (en) New octahydro - pyrrolo [3,4-c] - pyrrole derivatives and analogs thereof as autotaxin inhibitors
JO3433B1 (ar) حلقة كاربوكسامايد ذات أربع أعضاء للاستخدام كمبيدات النيماتودا
HUE057317T2 (hu) Helyettesített [1,2,4]triazolo[1,5-A]pirimidin-7-IL vegyületeket tartalmazó készítmények mint PDE2 inhibítorok
MX2020006237A (es) Compuestos para el tratamiento de enfermedades relacionadas con la expresion de dux4.
MX2016015762A (es) Derivados de alquilo y arilo de compuestos de 1-oxa-4,9-diazaspiro undecano que tienen actividad multimodal contra el dolor.
PH12017500839A1 (en) Triazolo[4,5-d]pyrimidines as agonists of the cannabinoid receptor 2
ZA201605666B (en) Pyrazolo[1,5-a]pyrimidines as antiviral compounds
EA201790603A1 (ru) Ингибиторы гистондеметилазы
MX2018013133A (es) Compuesto de pirazolo[1,5-a]pirimidina.
IL290419A (en) Imidazo[a-1,5]pyrazine derivatives as inhibitors of pi3k delta
IL267801A (en) Process for the preparation of 3-disubstituted 5-amino-h6-thiazolo[5,4-d]pyrimidine-7,2-dione compounds
IL272988A (en) Imidazo-[1,5-A]pyrazine derivatives as PI3K-delta inhibitors
MX2016000487A (es) Piridina-2-carboxamidas como nematicidas.
MX2017003415A (es) Un derivado de tetrahidropirrolo [3,4-d] [1,3]tiazina como inhibidor de bace.
AU2015221431A8 (en) Novel 6,7-dihydro-3H-oxazolo[3,4-a]pyrazine-5,8-dione derivative compounds
UA96860U (xx) Похідні [1,2,4]триазоло[4,3-а]піразину
TH1601003657A (th) อนุพันธ์ [1,2,4] ไตรอะโซโล [1,5-a]ไพริมิดีน ดังสารยับยั้งโปรเตียโซมของ โปรโตซัวสำหรับการรักษาของโรคที่เกิดจากปรสิต เช่น โรคลิชมาเนียซิส

Legal Events

Date Code Title Description
FG Grant or registration